Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849108 · ClinicalTrials.gov registry record · Phase 2
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
A Phase 2 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 2
- Development phase
- 176
- Enrollment target
NCT00849108: Completed Phase 2 study, sponsored by Lantheus Medical Imaging.
NCT00849108 is a Phase 2 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 176 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00849108, a Phase 2 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 176 participants
- Enrollment target
Study Summary
The main purpose of this study is to get more information on using BMS747158 (the study drug),a drug with small amounts of radioactivity to allow for heart imaging, during a PET scan which can then be compared to other images such as SPECT. The safety and quality of images will be studied.
Primary Outcome
The rest flurpiridaz dose to be used for subsequent efficacy studies was determined by a modeling method that simulated a range of injected doses using a single fixed injected dose at rest in each subject and a range of acquisition durations. From this, a dose acquisition time product (DATP was determined for each subject that specified the minimal dose for a given acquisition duration that yielded an image in that subject that was negligibly affected by photon counting statistics. Descriptive s
Interventions
- DRUG BMS747158
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
What the finished NCT00849108 record still lists
NCT00849108 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (32% higher).
The record links to 0 conditions, and to 1 intervention - of which BMS747158 is the first listed.
NCT00849108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00849108 about?
NCT00849108 is a clinical study titled "Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158". The main purpose of this study is to get more information on using BMS747158 (the study drug),a drug with small amounts of radioactivity to allow for heart imaging, during a PET scan which can then be compared to other images such as SPECT. The safety and quality of images will be studied.
What is the current status of trial NCT00849108?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 176 participants. The study started on 2009-01. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00849108?
The interventions under investigation include: BMS747158 (DRUG).
Who is sponsoring clinical trial NCT00849108?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00849108's enrollment target sits among peer trials
176 394th of 2000 higher than 1,605 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia